Clinical Trials Directory

Trials / Unknown

UnknownNCT04932330

Risk Factors of ICU-acquired Weakness

ICU-acquired Weakness in Extracorporeal Membrane Oxygenation Support: Frequency and Risk Factors

Status
Unknown
Phase
Study type
Observational
Enrollment
85 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

We conducted a retrospective study of critical ill patients who used ECMO during their ICU stay. ICU-AW was diagnosed at the time when patients discharged and had a Medical Research Council (MRC) sum score \< 48 out of a maximal score of 60. We divided patients to ICU-acquired weakness group and no ICU-acquired weakness group and compared their clinical characteristics. Baseline characteristics and therapy details were collected from the case report forms and inspection reports. Univariable analysis and logistic regression analysis were used to analyze clinical characteristics of individuals and to find risk factors of ICU-AW.

Conditions

Timeline

Start date
2017-03-01
Primary completion
2020-03-01
Completion
2022-06-01
First posted
2021-06-21
Last updated
2021-06-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04932330. Inclusion in this directory is not an endorsement.

Risk Factors of ICU-acquired Weakness (NCT04932330) · Clinical Trials Directory